Clinical trial
Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block for Creation of Arteriovenous Fistula in End Stage Renal Disease: A Randomized Controlled Trial
NCT06389617 is registered in ClinicalTrials.gov with Hospital Universiti Sains Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block for Creation of Arteriovenous Fistula in End Stage Renal Disease: A Randomized Controlled Trial
- Lead sponsor
- Hospital Universiti Sains Malaysia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2024
- Completion date
- December 30, 2024
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal failure